Alterations of hippocampal secreted N-CAM in bipolar disorder and synaptophysin in schizophrenia

Molecular Psychiatry

Volumn 4, Issue 5, 1999, Pages 467-475

  Vawter, M P ^a   Howard, A L ^a   Hyde, T M ^b   Kleinman, J E ^b   Freed, W J ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

Actin; Bipolar disorder; Hippocampus; Neural cell adhesion molecule; Schizophrenia; Secreted exon; Suicide; Synaptophysin; Western immunoblot

Indexed keywords

ACTIN; ANTIBODY; NERVE CELL ADHESION MOLECULE; SYNAPTOPHYSIN;

ARTICLE; CEREBROSPINAL FLUID LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; MANIC DEPRESSIVE PSYCHOSIS; NEUROPATHOLOGY; PRIORITY JOURNAL; PROTEIN SECRETION; SCHIZOPHRENIA; SUICIDE;

EID: 0032705455     PISSN: 13594184     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.mp.4000547     Document Type: Article

References (60)

1. 1 Torrey EF. Surviving Schizophrenia: A Manual for Families, Consumers, and Providers. Harper Perennial: New York, 1995.
2. 2 Bachus SE, Kleinman JE. The neuropathology of schizophrenia. J Clin Psychiatry 1996; 57 (Suppl 11): 72-83.
3. 3 Lachman HM, Papolos DF. A molecular model for bipolar affective disorder. Medical Hypotheses 1995; 45: 255-264.
4. 4 Nelson MD, Saykin AJ, Flashman LA, Riordan HJ. Hippocampal volume reduction in schizophrenia as assessed by magnetic resonance imaging: a meta-analytic study. Arch Gen Psychiatry 1998; 55: 433-440.
5. 5 Swayze VWd, Andreasen NC, Alliger RJ, Ehrhardt JC, Yuh WT. Structural brain abnormalities in bipolar affective disorder. Ventricular enlargement and focal signal hyperintensities. Arch Gen Psychiatry 1990; 47: 1054-1059.
6. 6 Swayze VWd, Andreasen NC, Alliger RJ, Yuh WT, Ehrhardt JC. Subcortical and temporal structures in affective disorder and schizophrenia: a magnetic resonance imaging study. Biol Psychiatry 1992; 31: 221-240.
7. 7 Owen F, Cross AJ, Crow TJ, Longden A, Poulter M, Riley GJ. Increased dopamine-receptor sensitivity in schizophrenia. Lancet 1978; 2: 223-226.
8. 8 Deakin JF, Simpson MD. A two-process theory of schizophrenia: evidence from studies in post-mortem brain. J Psychiatr Res 1997; 31: 277-295.
9. 9 Weinberger DR. Implications of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiatry 1987; 44: 660-669.
10. 10 Torrey EF, Yolken RH, Winfrey CJ. Cytomegalovirus antibody in cerebrospinal fluid of schizophrenic patients detected by enzyme immunoassay. Science 1982; 216: 892-894.
11. 11 Wright P, Gill M, Murray RM. Schizophrenia: genetics and the maternal immune response to viral infection. Am J Med Genet 1993; 48:40-46.
12. 12 Keshavan MS, Anderson S, Pettegrew JW. Is schizophrenia due to excessive synaptic pruning in the prefrontal cortex? The Feinberg hypothesis revisited. J Psychiatr Res 1994; 28: 239-265.
13. 13 Horrobin DF, Glen AI, Vaddadi K. The membrane hypothesis of schizophrenia. Schizophr Res 1994; 13: 195-207.
14. 14 Horrobin DF. The membrane phospholipid hypothesis as a biochemical basis for the neurodevelopmental concept of schizophrenia. Schizophrenia Res 1998; 30: 193-208.
15. 15 Mayford M, Barzilai A, Keller F, Schacher S, Kandel ER. Modulation of an NCAM-related adhesion molecule with long-term synaptic plasticity in Aplysia. Science 1992; 256: 638-644.
16. 16 Rutishauser U, Jessel TM. Cell adhesion molecules in vertebrate neural development. Physiol Rev 1988; 68: 819-857.
17. 17 Baldwin TJ, Fazeli MS, Doherty P, Walsh FS. Elucidation of the molecular actions of NCAM and structurally related cell adhesion molecules. J Cell Biochem 1996; 61: 502-513.
18. 18 Fields RD, Itoh K. Neural cell adhesion molecules in activity-dependent development and synaptic plasticity. Trends Neurosci 1996; 19: 473-480.
19. 19 Jorgensen OS. Neural cell adhesion molecule (NCAM) as a quantitative marker in synaptic remodeling. Neurochem Res 1995; 20: 533-547.
20. 20 Luthl A, Laurent JP, Figurov A, Muller D, Schachner M. Hippocampal long-term potentiation and neural cell adhesion molecules L1 and NCAM. Nature 1994; 372: 777-779.
21. 21 Ronn LC, Bock E, Linnemann D, Jahnsen H. NCAM-antibodies modulate induction of long-term potentiation in rat hippocampal CA1. Brain Res 1995; 677: 145-151.
22. 22 Rose SP. Cell-adhesion molecules, glucocorticoids and long-term-memory formation. Trends Neurosci 1995; 18: 502-506.
23. 23 Izaki Y, Arita J. Long-term potentiation in the rat hippocampal CA1 region is inhibited selectively at the acquisition stage of discriminatory avoidance learning. Brain Res 1996; 723: 162-168.
24. 24 Poltorak M, Khoja I, Hemperly JJ, Williams JR, el-Mallakh R, Freed WJ. Disturbances in cell recognition molecules (N-CAM and L1 antigen) in the CSF of patients with schizophrenia. Exp Neurol 1995; 131: 266-272.
25. 25 Poltorak M, Frye M, Wright R et al. Increased neural cell adhesion molecule in the CSF of patients with mood disorder. J Neurochem 1996; 66: 1532-1538.
26. 26 Honer WG, Falkai P, Young C et al. Cingulate cortex synaptic terminal proteins and neural cell adhesion molecule in schizophrenia. Neuroscience 1997; 78: 99-110.
27. 27 Vawter MP, Cannon-Spoor HE, Hemperly JJ et al. Abnormal expression of cell recognition molecules in schizophrenia. Exp Neurol 1998; 149: 424-432.
28. 28 Vawter MP, Hemperly JJ, Hyde TM et al. VASE-containing N-CAM isoforms are increased in the hippocampus in bipolar disorder but not in schizophrenia. Exp Neurol 1998; 154: 1-11.
29. 29 Gower HJ, Barton CH, Elsom VL et al. Alternative splicing generates a secreted form of N-CAM in muscle and brain. Cell 1988; 55: 955-964.
30. 30 Navone F, Jahn R, Di Gioia G, Stukenbrok H, Greengard P, De Camilli P. Protein p 38: an integral membrane protein specific for small vesicles of neurons and neuroendocrine cells. J Cell Biol 1986; 103: 2511-2527.
31. 31 McMahon HT, Bolshakov VY, Janz R, Hammer RE, Siegelbaum SA, Sudhof TC. Synaptophysin, a major synaptic vesicle protein, is not essential for neurotransmitter release. Proc Natl Acad Sci USA 1996; 93: 4760-4764.
32. 32 DeKosky ST, Scheff SW, Styren SD. Structural correlates of cognition in dementia: quantification and assessment of synapse change. Neurodegeneration 1996; 5: 417-421.
33. 33 Eastwood SL, Harrison PJ. Decreased synaptophysin in the medial temporal lobe in schizophrenia demonstrated using immunoautoradiography. Neuroscience 1995; 69: 339-343.
34. 34 Eastwood SL, Burnet PW, Harrison PJ. Altered synaptophysin expression as a marker of synaptic pathology in schizophrenia. Neuroscience 1995; 66: 309-319.
35. 35 Young CE, Arima K, Xie J et al. SNAP-25 deficit and hippocampal connectivity in schizophrenia. Cereb Cortex 1998; 8: 261-268.
36. 36 Browning MD, Dudek EM, Rapier JL, Leonard S, Freedman R. Significant reductions in synapsin but not synaptophysin specific activity in the brains of some schizophrenics. Biol Psychiatry 1993; 34: 529-535.
37. 37 Glantz LA, Lewis DA. Reduction of synaptophysin immunoreactivity in the prefrontal cortex of subjects with schizophrenia. Regional and diagnostic specificity. Arch Gen Psychiatry 1997; 54: 660-669.
38. 38 Perrone-Bizzozero NI, Sower AC, Bird ED, Benowitz LI, Ivins KJ, Neve RL. Levels of the growth-associated protein GAP-43 are selectively increased in association cortices in schizophrenia. Proc Natl Acad Sci USA 1996; 93: 14182-14187.
39. 39 Gabriel SM, Haroutunian V, Powchik P et al. Increased concentrations of presynaptic proteins in the cingulate cortex of subjects with schizophrenia. Arch Gen Psychiatry 1997; 54: 559-566.
40. 40 Bachus SE, Hyde TM, Akil M, Weickert CS, Vawter MP, Kleinman JE. Neuropathology of suicide. A review and an approach. Ann N Y Acad Sci 1997; 836: 201-219.
41. 41 Inskip HM, Harris EC, Barraclough B. Lifetime risk of suicide for affective disorder, alcoholism and schizophrenia. Br J Psychiatry 1998; 172: 35-37.
42. 42 Faissner A, Teplow DB, Kubler D, Keilhauer G, Kinzel V, Schachner M. Biosynthesis and membrane topography of the neural cell adhesion molecule L1. Embo J 1985; 4: 3105-3113.
43. 43 Suneja SK, Potashner SJ. Quantification of a neurotrophin receptor from submilligram quantities of brain tissue using western blotting. Brain Res Brain Res Protoc 1998; 3: 88-93.
44. 44 Hershman KM, Fleming WW, Taylor DA. A quantitative method for assessing protein abundance using enhanced chemiluminescence. Biotechniques 1993; 15: 790, 792, 794 passim.
45. 45 Kingsbury AE, Foster OJ, Nisbel AP et al. Tissue pH as an indicator of mRNA preservation in human post-mortem brain. Brain Res Mol Brain Res 1995; 28: 311-318.
46. 46 Johnston NL, Cervenak J, Shore AD, Torrey EF, Yolken RH, Cerevnak J. Multivariate analysis of RNA levels from postmortem human brains as measured by three different methods of RT-PCR. Stanley Neuropathology Consortium. J Neurosci Meth 1997; 77: 83-92.
47. 47 Liu X, Brun A. Synaptophysin immunoreactivity is stable 36 h postmortem. Dementia 1995; 6: 211-217.
48. 48 Davidsson P, Blennow K. Neurochemical dissection of synaptic pathology in Alzheimer's disease. Int Psychogeriatr 1998; 10: 11-23.
49. 49 Jorgensen OS, Brooksbank BW, Balazs R. Neuronal plasticity and astrocytic reaction in Down syndrome and Alzheimer disease. J Neurol Sci 1990; 98: 63-79.
50. 50 Doherty P, Fazeli MS, Walsh FS. The neural cell adhesion molecule and synaptic plasticity. J Neurobiol 1995; 26: 437-446.
51. 51 Cremer H, Chazal G, Goridis C, Represa A. NCAM is essential for axonal growth and fasciculation in the hippocampus. Mol Cell Neurosci 1997; 8: 323-335.
52. 52 Whitesides JGd, LaMantia AS. Distinct adhesive behaviors of neurons and neural precursor cells during regional differentiation in the mammalian forebrain. Dev Biol 1995; 169: 229-241.
53. 53 Fox GB, O'Connell AW, Murphy KJ, Regan CM. Memory consolidation induces a transient and time-dependent increase in the frequency of neural cell adhesion molecule polysialylated cells in the adult rat hippocampus. J Neurochem 1995; 65: 2796-2799.
54. 54 Smith GM, Jacobberger JW, Miller RH. Modulation of adhesion molecule expression on rat cortical astrocytes during maturation. J Neurochem 1993; 60: 1453-1466.
55. 55 Edvardsen K, Chen W, Rucklidge G, Walsh FS, Obrink B, Bock E. Transmembrane neural cell-adhesion molecule (NCAM), but not glycosyl-phosphatidylinositol-anchored NCAM, down-regulates secretion of matrix metalloproteinases. Proc Natl Acad Sci USA 1993; 90: 11463-11467.
56. 56 Eastwood SL, Harrison PJ. Decreased synaptophysin in the medial temporal lobe in schizophrenia demonstrated using immunoauturadiography. Neuroscience 1995; 69: 339-343.
57. 57 Toherepanov AA, Sokolov BP. Age-related abnormalities in expression of mRNAs encoding synapsin 1A, synapsin 1B, and synaptophysin in the temporal cortex of schizophrenics. J Neurosci Res 1997; 49: 639-644.
58. 58 Rosahl TW, Spillane D, Missler M et al. Essential functions of synapsins I and II in synaptic vesicle regulation. Nature 1995; 375: 488-493.
59. 59 Sze CI, Troncoso JC, Kawas C, Mouton P, Price DL, Martin LJ. Loss of the presynaptic vesicle protein synaptophysin in hippocampus correlates with cognitive decline in Alzheimer disease. J Neuropathol Exp Neurol 1997; 56: 933-944.
60. 60 Heinrichs RW, Zakzanis KK. Neurocognitive deficit in schizophrenia: a quantitative review of the evidence. Neuropsychology 1998; 12: 426-445.